Adicet Bio to Present at the Cantor Virtual Global Healthcare Conference
MENLO PARK, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer of Adicet Bio, will present at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 8:40 AM ET.
A live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.om. An archived replay will be available for 30 days following the presentation.
About Adicet Bio, Inc.
Adicet Bio., Inc.
AI Use Case
The New Era of Wireless Access and the Great Disconnect